WisdomTree Cloud Computing Fund (WCLD)
Live price chart, market sentiment, and community perspectives for WisdomTree Cloud Computing Fund (NASDAQ: WCLD).
Live price chart, market sentiment, and community perspectives for WisdomTree Cloud Computing Fund (NASDAQ: WCLD).
On our desk, growth investors are definitely getting cold feet about AI spend. Watching WCLD drop 30.5% over the past year to $28.60 highlights a massive divergence from the broader SandP 500's gains, proving that high-beta cloud software is facing an existential valuation reassessment driven by rate sensitivity and disruption fears.
Looking at the short interest data as of July 15, 2026, WCLD short interest sat at 1.26 million shares, representing 16.86% of the public float after a -24.82% decrease. This contraction in short bets indicates that while sentiment is deeply cautious due to the 'SaaS Apocalypse,' aggressive shorting may be cooling off as some names attempt to bottom.
When analyzing cloud infrastructure versus application software, our protocol separates large-cap infrastructure heavyweights like Oracle and Microsoft from WCLD's higher-beta holdings. While infrastructure names show stabilization, WCLD components like HubSpot, Paycom, SailPoint, and Zscaler remain vulnerable to rapid market shifts and changing enterprise IT budgets.
From a risk management standpoint, the divergence between funds like SKYY—which leans toward stable infrastructure—and WCLD points to severe structural concentration risks. High-beta software names inside WCLD are being heavily penalized by investors questioning whether emerging cloud business models can withstand aggressive AI platform shifts.
In evaluating enterprise digital transformation protocols for 2026, we see two opposing forces: accelerated enterprise AI spending driving robust platform usage, weighed directly against fears that AI will cannibalize traditional software revenue streams. Navigating this requires strict monitoring of short-term moving averages and sector-wide beta exposure.
Explore plasma cleansing, somatic organ swaps, and BCI.